Infections in neutropenic patients. II: Management.
Improvement in supportive care including the introduction of new antibiotics, antiviral and antifungal agents and haematopoietic growth factors have all contributed to a decreased chemotherapy-related mortality and morbidity in cancer patients. However, infection during neutropenia is still a major complication and a great concern for the clinician responsible for the patient. Management of infectious complications in the neutropenic patient is reviewed.
Engervall
P
P
Department of Medicine, Karolinska Hospital, Stockholm, Sweden.
Björkholm
M
M
D000970:Antineoplastic Agents / Q000009:adverse effects*; D003115:Colony-Stimulating Factors / Q000627:therapeutic use; D006098:Granulocytes / Q000637:transplantation; D019337:Hematologic Neoplasms / Q000150:complications / Q000628:therapy*; D006801:Humans; D009503:Neutropenia / Q000150:complications*; D009894:Opportunistic Infections / Q000150:complications / Q000188:drug therapy*; D011878:Radiotherapy / Q000009:adverse effects
D000970:Antineoplastic Agents; D003115:Colony-Stimulating Factors